Socioeconomic inequality in oral anticoagulation therapy initiation in patients with atrial fibrillation with high risk of stroke: a register-based observational study.

Abstract

OBJECTIVE:

The study aimed to examine the association between socioeconomic factors (SEFs) and oral anticoagulation (OAC) therapy and whether it was influenced by changing guidelines. We hypothesised that inequities in initiation of OAC reduced over time as more detailed and explicit clinical guidelines were issued.

DESIGN:

Register-based observational study.

SETTINGS:

All Danish patients with an incident hospital diagnosis of atrial fibrillation (AF), aged ≥30 years old and with high risk of stroke from 1 May 1999 to 2 October 2015 were included. Absolute risk differences (RD) (95% CI) were used to measure the association.

PARTICIPANTS:

154 448 patients (mean age 78.2 years, men 47.3%).

EXPOSURE:

Education, family income and cohabiting status were the SEFs used as exposure.

OUTCOME:

A prescription of OAC within -30 to +90 days of baseline (incident AF).

RESULTS:

During 2002-2007, the crude RD of initiation of OAC for men with high education was 14.9% (12.8 to 16.9). Inequality reduced when new guidelines were published, and in 2013-2016 the crude RD was 5.6% (3.5 to 7.7). After adjusting for age, the RD substantially reduced. The same pattern was seen for cohabiting status, while inequality was smaller and more constant for income.

CONCLUSION:

Patients with low income, low education and living alone were associated with lower chance of being initiated with OAC. For education and cohabiting status, the crude difference reduced around 2011, when more detailed clinical guidelines were implemented in Denmark. Our results indicate that new guidelines might reduce inequality in OAC initiation and that new, high-cost drugs increase inequality.

• Authors: Elin Danielsen Lunde, Albert Marni Joensen, Kirsten Fonager, Søren Lundbye-Christensen, Søren Paaske Johnsen, Mogens Lytken Larsen, Gregory Y H Lip, Sam Riahi
• Journal: BMJ open (BMJ Open) Vol. 11 Issue 5 Pg. e048839 (05 31 2021) ISSN: 2044-6055 [Electronic] England
• PMID: 34059516 (Publication Type: Journal Article, Observational Study, Research Support, Non-U.S. Gov't)
• Copyright: © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Chemical References

• Anticoagulants

Topics

• Administration, Oral
• Adult
• Aged
• Anticoagulants (therapeutic use)
• Atrial Fibrillation (drug therapy)
• Humans
• Male
• Risk Factors
• Socioeconomic Factors
• Stroke (drug therapy, epidemiology, prevention & control)